TrialBMC infectious diseases2016

Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.

Ho Namkoong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.